Apotheca Biosciences, Inc. (CBDC) financial statements (2020 and earlier)

Company profile

Business Address 10901 ROOSEVELT BLVD.,
SAINT PETERSBURG, FL 33716
State of Incorp. NV
Fiscal Year End January 31
SIC 10 - Metal Mining (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

4/30/2019
Q1
1/31/2019
Q4
10/31/2018
Q3
7/31/2018
Q2
4/30/2018
Q1
1/31/2018
Q4
10/31/2017
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments2503168   1
Cash and cash equivalents2503168   1
Inventory, net of allowances, customer advances and progress billings1048     
Inventory1048     
Prepaid expense66     
Deposits current assets 66    
Other undisclosed current assets186     
Total current assets:361109174   1
Noncurrent Assets
Property, plant and equipment86     
Intangible assets, net (including goodwill)1      
Intangible assets, net (excluding goodwill)1      
Other undisclosed noncurrent assets134      
Total noncurrent assets:1426     
TOTAL ASSETS:503115174   1
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:187107852,00020180
Accounts payable28243415   
Accrued liabilities15983511,985   
Interest and dividends payable      3
Other undisclosed accounts payable and accrued liabilities    2018(2)
Debt191919  157130
Due to related parties248419194747
Other undisclosed current liabilities952  (0)  3
Total current liabilities:1,1821341072,01838222180
Noncurrent Liabilities
Other undisclosed noncurrent liabilities31      
Total noncurrent liabilities:31      
Other undisclosed liabilities 798588    
Total liabilities:1,2139326952,01838222180
Stockholders' equity
Stockholders' equity attributable to parent, including:(710)(817)(521)(2,509)(38)(222)(180)
Common stock11911811451515050
Additional paid in capital1,5961,504(303)438423171
Accumulated deficit(2,515)(2,512)(405)(2,508)(513)(290)(231)
Other undisclosed stockholders' equity attributable to parent917474(490)   
Other undisclosed stockholders' equity   404   
Total stockholders' equity:(710)(817)(521)(2,105)(38)(222)(180)
TOTAL LIABILITIES AND EQUITY:503115174(87)  1

Income statement (P&L) ($ in thousands)

4/30/2019
Q1
1/31/2019
Q4
10/31/2018
Q3
7/31/2018
Q2
4/30/2018
Q1
1/31/2018
Q4
10/31/2017
Q3
Gross profit:     (27)(35)
Operating expenses(299)(2,028)(156)(10)(16)(44)(41)
Other undisclosed operating income     62 
Operating loss:(299)(2,028)(156)(10)(16)(9)(76)
Nonoperating income (expense)296(79)(157)(1,985)(207)  
Interest and debt expense(3)   (201)  
Other undisclosed loss from continuing operations before equity method investments, income taxes     (8) 
Loss before gain (loss) on sale of properties:(6)(2,107)(313)(1,995)(425)(16)(76)
Other undisclosed net income3      
Net loss:(3)(2,107)(313)(1,995)(425)(16)(76)
Other undisclosed net income (loss) attributable to parent    201(30)33
Net loss available to common stockholders, diluted:(3)(2,107)(313)(1,995)(223)(47)(43)

Comprehensive Income ($ in thousands)

4/30/2019
Q1
1/31/2019
Q4
10/31/2018
Q3
7/31/2018
Q2
4/30/2018
Q1
1/31/2018
Q4
10/31/2017
Q3
Net loss:(3)(2,107)(313)(1,995)(425)(16)(76)
Comprehensive loss, net of tax, attributable to parent:(3)(2,107)(313)(1,995)(425)(16)(76)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: